JOURNAL ARTICLE
Add like
Add dislike
Add to saved papers

A retrospective study in management of carotid body tumour.

We report our experience of the management of 53 patients with 57 carotid body tumours from two units of oral and maxillofacial surgery in China between 1995 and 2006. Digital subtraction angiography was used most often for the confirmation of diagnosis and preoperative assessment. Fifty-one patients with 55 tumours had their tumours resected and 2 patients had radiotherapy. Of the 55 excised tumours, 14 were resected successfully without injury to the carotid artery, 25 were resected with the external carotid artery, 5 had arteriorrhaphy, and 11 resulted in sacrificing the unilateral internal carotid artery (ICA). Six patients had interposition reconstruction of the ICA. Immediately after operation 14 patients (27%) had neurological damage, which was permanent in 3 (6%), and 2 (4%) developed stroke. There were no deaths. Once the ICA is resected, vascular reconstruction is recommended to minimise neurological morbidity.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app